politics

Teplizumab, a drug that delays type 1 diabetes onset, approved in England and Wales

23 Haziran 2026The Guardian

Teplizumab, the first drug approved to delay the onset of type 1 diabetes, will soon be available on the NHS in England and Wales. This groundbreaking treatment can postpone the early stages of the disease for up to three years, marking a significant advancement in diabetes care.
Type 1 diabetes, which often develops in childhood or adolescence, results from the pancreas producing little or no insulin.
Type 1 diabetes is a lifelong condition that affects how the body processes glucose, leading to serious health complications if not managed properly. The introduction of teplizumab is seen as a major step forward, given that previous treatments have focused primarily on managing symptoms rather than delaying disease…
The approval of teplizumab represents a pivotal moment in the management of type 1 diabetes, offering hope to millions affected by this chronic condition. By delaying the onset of the disease, this drug not only improves the quality of life for patients but also reduces the immediate healthcare burden associated wit…

NewsAI özeti

This article is for informational purposes only and should not be considered medical advice.

Tam teknik rapor ve canlı veriler için yayıncının web sitesini ziyaret edin.

Her yerde okuyun. iOS ve Android için ödüllü uygulamalarımızı indirin.